Arvato expands European partnership with argenx

11 June 2025

Germany-based Arvato and Dutch immunology specialist argenx (Euronext: ARGX) have successfully achieved two important milestones in their European expansion. Following the launch of direct distribution for the Spanish market from Alcalá de Henares, the Italian market is now also being served from Arvato’s logistics site in Calcinate near Bergamo.

The partnership between Arvato and argenx began in 2022, and has since evolved  into a comprehensive collaboration across the EMEA region. Arvato has been managing argenx’ German logistics from its Healthcare hub in Harsewinkel (North Rhine-Westphalia), delivering a comprehensive order-to-cash service, from warehouse management to order processing and shipping, along with other value-added services.

The Go Live in Spain earlier this year marked the starting point of the international expansion of the partnership and the next milestone has already been reached with the Go Live of the services for the Italian market. The Arvato site in Calcinate near Bergamo now serves as a central distribution hub for argenx and covers the complete country.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Company News Directory



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology